• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 488761 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414797455 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414797455 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Buyers Accumulate Shares of BioMarin Pharmaceutical, Up 3.4%

Published on Mon, 04/29/2013 - 12:17
By Adrienne Chilton

One of today's stocks on the move is BioMarin Pharmaceutical (NASDAQ:BMRN), up 3.4% to $65.32. The S&P is trading higher by 0.8% to 1,595 and the Dow is trading 0.7% higher to 14,814.

Over the past year, BioMarin Pharmaceutical has traded in a range of $34.30 to $66.63 and is now at $65.32, 90% above that low. Over the past week, the 200-day moving average (MA) has gone up 1.2% while the 50-day MA has advanced 1.5%.

BioMarin Pharmaceutical Inc. develops and commercializes therapeutic enzyme products. The Company has applied its proprietary enzyme technology to develop products for lysosomal storage diseases and for the treatment of serious burns. BioMarin's subsidiary provides analytical and diagnostic products and services in the area of carbohydrate biology.

BioMarin Pharmaceutical (NASDAQ:BMRN) is currently priced 3.3% above its average consensus analyst price target of $63.13. The stock should find initial support at its 50-day moving average (MA) of $60.86 and further support at its 200-day MA of $48.77.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Zimmer Looks to Continue to Trade Above ...

Shares of Zimmer (NYSE:ZMH) traded today at $111.21, breaking its 52-week high. This n ...

Shares of Yahoo! Rise to a New 52-Week H...

Yahoo! (NASDAQ:YHOO) traded at a new 52-week high today of $46.52. So far today approx ...

Shares of Aqua America Rise to a New 52-...

Shares of Aqua America (NYSE:WTR) traded at a new 52-week high today of $26.42. This n ...

West Pharmaceutical Services: 52-Week Hi...

Shares of West Pharmaceutical Services (NYSE:WST) traded today at $51.63, breaking its ...

Recent 52-Week High Exceeded in Shares o...

Shares of WesBanco (NASDAQ:WSBC) traded at a new 52-week high today of $34.94. This ne ...

Recent 52-Week High Exceeded in Shares o...

Weingarten Realty Investors (NYSE:WRI) traded at a new 52-week high today of $36.02. S ...

Shares of WR Berkley Rise to a New 52-We...

WR Berkley (NYSE:WRB) traded today at a new 52-week high of $51.63. This new high was ...

VCA Antech: 52-Week High Recently Eclips...

Shares of VCA Antech (NASDAQ:WOOF) traded at a new 52-week high today of $45.94. So fa ...